Man Group PLC Acadia Pharmaceuticals Inc Transaction History
Man Group PLC
- $38.1 Billion
- Q1 2024
A detailed history of Man Group PLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Man Group PLC holds 50,301 shares of ACAD stock, worth $817,391. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,301
Previous 32,220
56.12%
Holding current value
$817,391
Previous $1.01 Million
7.74%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ACAD
# of Institutions
299Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$697 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$225 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$216 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$190 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$97.5 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.63B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...